Thomas Prescott Atkinson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Prescott Atkinson has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Arthur H. Totten
Department of Pathology, Stony Brook University Hospital
5 shared publications Li Xiao
Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
5 shared publications- Kevin Dybvig
Affiliation Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States of America
3 shared publications - Li Xiao
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
3 shared publications - Anna C. E. Hurst
Department of Genetics, University of Alabama at Birmingham, Birmingham, USA
2 shared publications Arthur H. Totten
Department of Pediatrics, University of Alabama at Birmingham
2 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (Supplement) , S1390-S1397
Disulfiram Exhibits Potent Copper-Dependent Antimicrobial Activity Against Mycoplasma genitalium
Background: Mycoplasma genitalium (Mgen) is a sexually transmitted urogenital pathogen. Studies in sexual health clinic settings have demonstrated that Mgen infection, with similar prevalence to Chlamydia trachomatis infection, is becoming increasingly resistant to the limited classes of antibiotics with in vitro and clinical activity. Disulfiram (DS) is a Food and Drug Administration–approved drug for treatment of alcohol dependence that shows promise for repurposing as an antimicrobial agent. Methods: Minimum inhibitory concentration was performed via standard methods for human mycoplasmas and ureaplasmas as established by guideline M43-A of the Clinical and Laboratory Standards Institute. Mgen strain G37 was used as a part of a colorimetric checkboard assay to explore the mechanism of growth inhibition with DS, with emphasis on the role of copper on DS antimicrobial activity. Trace concentrations of radioactive 64Cu were used to understand Cu2+ trafficking and probe the antimicrobial mechanism of DS for strain G37 and 2 DS-resistant mutants (D3 and D4). Results: DS exhibits in vitro antimicrobial activity against Mgen isolates with low minimum inhibitory concentration values, regardless of susceptibility to other antibiotics. Growth inhibition studies with DS demonstrated that antimicrobial activity is copper dependent. Studies with 64Cu showed that DS greatly enhances copper uptake but that impaired DS-mediated copper uptake is not the mechanism for DS-resistance in Mgen mutants D3 and D4. Conclusions: DS exhibits potent copper-dependent antimicrobial activity against Mgen. DS or a similar compound could be developed as therapy for drug-resistant Mgen infections.
- 30 March 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (Supplement) , S1390-S1397
Open AccessDisulfiram Exhibits Potent Copper-Dependent Antimicrobial Activity Against Mycoplasma genitalium
Background: Mycoplasma genitalium (Mgen) is a sexually transmitted urogenital pathogen. Studies in sexual health clinic settings have demonstrated that Mgen infection, with similar prevalence to Chlamydia trachomatis infection, is becoming increasingly resistant to the limited classes of antibiotics with in vitro and clinical activity. Disulfiram (DS) is a Food and Drug Administration–approved drug for treatment of alcohol dependence that shows promise for repurposing as an antimicrobial agent. Methods: Minimum inhibitory concentration was performed via standard methods for human mycoplasmas and ureaplasmas as established by guideline M43-A of the Clinical and Laboratory Standards Institute. Mgen strain G37 was used as a part of a colorimetric checkboard assay to explore the mechanism of growth inhibition with DS, with emphasis on the role of copper on DS antimicrobial activity. Trace concentrations of radioactive 64Cu were used to understand Cu2+ trafficking and probe the antimicrobial mechanism of DS for strain G37 and 2 DS-resistant mutants (D3 and D4). Results: DS exhibits in vitro antimicrobial activity against Mgen isolates with low minimum inhibitory concentration values, regardless of susceptibility to other antibiotics. Growth inhibition studies with DS demonstrated that antimicrobial activity is copper dependent. Studies with 64Cu showed that DS greatly enhances copper uptake but that impaired DS-mediated copper uptake is not the mechanism for DS-resistance in Mgen mutants D3 and D4. Conclusions: DS exhibits potent copper-dependent antimicrobial activity against Mgen. DS or a similar compound could be developed as therapy for drug-resistant Mgen infections.
- Open Access
- 22 August 2025
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 1 (4)
A compound heterozygous case of leukocyte adhesion deficiency type-1 with moderate CD18 expression and severe disease
A child with severe leukocyte adhesion deficiency type-1 (LAD-1) was found to have compound heterozygous ITGB2 mutations. Despite moderate CD18 expression, the patient experienced life-threatening infections, demonstrating that protein levels do not always correlate with clinical severity.
- 22 August 2025
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 1 (4)
Open AccessA compound heterozygous case of leukocyte adhesion deficiency type-1 with moderate CD18 expression and severe disease
A child with severe leukocyte adhesion deficiency type-1 (LAD-1) was found to have compound heterozygous ITGB2 mutations. Despite moderate CD18 expression, the patient experienced life-threatening infections, demonstrating that protein levels do not always correlate with clinical severity.
- 15 November 2022
- Published by Springer Nature
- p. 325-351
Monoclonal Gammopathies with Miscellaneous Associations
- 15 November 2022
- Published by Springer Nature
- p. 325-351
Monoclonal Gammopathies with Miscellaneous Associations
- Open Access
- 5 May 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients
The pioneer transcription factor (TF) PU.1 controls hematopoietic cell fate by decompacting stem cell heterochromatin and allowing nonpioneer TFs to enter otherwise inaccessible genomic sites. PU.1 deficiency fatally arrests lymphopoiesis and myelopoiesis in mice, but human congenital PU.1 disorders have not previously been described. We studied six unrelated agammaglobulinemic patients, each harboring a heterozygous mutation (four de novo, two unphased) of SPI1, the gene encoding PU.1. Affected patients lacked circulating B cells and possessed few conventional dendritic cells. Introducing disease-similar SPI1 mutations into human hematopoietic stem and progenitor cells impaired early in vitro B cell and myeloid cell differentiation. Patient SPI1 mutations encoded destabilized PU.1 proteins unable to nuclear localize or bind target DNA. In PU.1-haploinsufficient pro–B cell lines, euchromatin was less accessible to nonpioneer TFs critical for B cell development, and gene expression patterns associated with the pro– to pre–B cell transition were undermined. Our findings molecularly describe a novel form of agammaglobulinemia and underscore PU.1’s critical, dose-dependent role as a hematopoietic euchromatin gatekeeper.
- 5 May 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
Open AccessConstrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients
The pioneer transcription factor (TF) PU.1 controls hematopoietic cell fate by decompacting stem cell heterochromatin and allowing nonpioneer TFs to enter otherwise inaccessible genomic sites. PU.1 deficiency fatally arrests lymphopoiesis and myelopoiesis in mice, but human congenital PU.1 disorders have not previously been described. We studied six unrelated agammaglobulinemic patients, each harboring a heterozygous mutation (four de novo, two unphased) of SPI1, the gene encoding PU.1. Affected patients lacked circulating B cells and possessed few conventional dendritic cells. Introducing disease-similar SPI1 mutations into human hematopoietic stem and progenitor cells impaired early in vitro B cell and myeloid cell differentiation. Patient SPI1 mutations encoded destabilized PU.1 proteins unable to nuclear localize or bind target DNA. In PU.1-haploinsufficient pro–B cell lines, euchromatin was less accessible to nonpioneer TFs critical for B cell development, and gene expression patterns associated with the pro– to pre–B cell transition were undermined. Our findings molecularly describe a novel form of agammaglobulinemia and underscore PU.1’s critical, dose-dependent role as a hematopoietic euchromatin gatekeeper.
- Open Access
- 26 April 2021
- Published by Microbiology Society in Access Microbiology
- Vol. 3 (4) , 000221
Septic polyarthritis with Mycoplasma salivarium in a patient with common variable immunodeficiency: case report and review of the literature
Mycoplasma salivarium is a common mycoplasma usually isolated from human oropharynx, particularly from individuals with periodontal disease. It is also among the more common mycoplasmal contaminants of eukaryotic cell cultures. Although M. salivarium has been isolated occasionally from abscesses and other sterile sites, to our knowledge, only three cases of septic arthritis have been documented in the past due to this organism, all in patients with humoral immunodeficiency. We now report a fourth case of septic polyarthritis in a patient with profound hypoimmunoglobulinemia who had experienced dental abscesses within the preceding 2 years. Our case highlights the importance of considering invasive mycoplasmal infection in hypogammaglobulinemic patients. It is likely of significance that the patient had suffered recurrent dental abscesses as a source of infection with M. salivarium .
- 26 April 2021
- Published by Microbiology Society in Access Microbiology
- Vol. 3 (4) , 000221
Open AccessSeptic polyarthritis with Mycoplasma salivarium in a patient with common variable immunodeficiency: case report and review of the literature
Mycoplasma salivarium is a common mycoplasma usually isolated from human oropharynx, particularly from individuals with periodontal disease. It is also among the more common mycoplasmal contaminants of eukaryotic cell cultures. Although M. salivarium has been isolated occasionally from abscesses and other sterile sites, to our knowledge, only three cases of septic arthritis have been documented in the past due to this organism, all in patients with humoral immunodeficiency. We now report a fourth case of septic polyarthritis in a patient with profound hypoimmunoglobulinemia who had experienced dental abscesses within the preceding 2 years. Our case highlights the importance of considering invasive mycoplasmal infection in hypogammaglobulinemic patients. It is likely of significance that the patient had suffered recurrent dental abscesses as a source of infection with M. salivarium .
- Open Access
- 27 October 2020
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11, 585524
Mycoplasma genitalium Biofilms Contain Poly-GlcNAc and Contribute to Antibiotic Resistance
Mycoplasma genitalium is an important etiologic agent of non-gonococcal urethritis (NGU), known for chronicity and multidrug resistance, in which biofilms may play an integral role. In some bacterial species capable of forming biofilms, extracellular polymeric substances (EPS) composed of poly-N-acetylglucosamine (PNAG) are a crucial component of the matrix. Monosaccharide analysis of M. genitalium strains revealed high abundance of GlcNAc, suggesting a biofilm-specific EPS. Chromatograms also showed high concentrations of galactose and glucose as observed in other mycoplasma species. Fluorescence microscopy of M. genitalium biofilms utilizing fluor-coupled lectins revealed differential staining of biofilm structures. Scanning electron microscopy (SEM) showed increasing maturation over time of bacterial “towers” seen in biofilm development. As seen with Mycoplasma pneumoniae, organisms within fully mature M. genitalium biofilms exhibited loss of cell polarization. Bacteria associated with disrupted biofilms exhibited decreased dose-dependent viability after treatment with antibiotics compared to bacteria with intact biofilms. In addition, growth index analysis demonstrated decreases in metabolism in cultures with disrupted biofilms with antibiotic treatment. Taken together, these data suggest that M. genitalium biofilms are a contributing factor in antibiotic resistance.
- 27 October 2020
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11, 585524
Open AccessMycoplasma genitalium Biofilms Contain Poly-GlcNAc and Contribute to Antibiotic Resistance
Mycoplasma genitalium is an important etiologic agent of non-gonococcal urethritis (NGU), known for chronicity and multidrug resistance, in which biofilms may play an integral role. In some bacterial species capable of forming biofilms, extracellular polymeric substances (EPS) composed of poly-N-acetylglucosamine (PNAG) are a crucial component of the matrix. Monosaccharide analysis of M. genitalium strains revealed high abundance of GlcNAc, suggesting a biofilm-specific EPS. Chromatograms also showed high concentrations of galactose and glucose as observed in other mycoplasma species. Fluorescence microscopy of M. genitalium biofilms utilizing fluor-coupled lectins revealed differential staining of biofilm structures. Scanning electron microscopy (SEM) showed increasing maturation over time of bacterial “towers” seen in biofilm development. As seen with Mycoplasma pneumoniae, organisms within fully mature M. genitalium biofilms exhibited loss of cell polarization. Bacteria associated with disrupted biofilms exhibited decreased dose-dependent viability after treatment with antibiotics compared to bacteria with intact biofilms. In addition, growth index analysis demonstrated decreases in metabolism in cultures with disrupted biofilms with antibiotic treatment. Taken together, these data suggest that M. genitalium biofilms are a contributing factor in antibiotic resistance.
- 5 October 2020
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (7) , e1454-e1455
Candidatus Mycoplasma haemohominis: Emerging Infection in New Caledonia
- 5 October 2020
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (7) , e1454-e1455
Candidatus Mycoplasma haemohominis: Emerging Infection in New Caledonia
- 1 January 2020
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (1) , 358-367.e2
Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome
- 1 January 2020
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (1) , 358-367.e2
Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome